Literature DB >> 36249052

The effects of radiation therapy on the macrophage response in cancer.

Callum Beach1, David MacLean1, Dominika Majorova1, James N Arnold2, Monica M Olcina1.   

Abstract

The efficacy of radiotherapy, a mainstay of cancer treatment, is strongly influenced by both cellular and non-cellular features of the tumor microenvironment (TME). Tumor-associated macrophages (TAMs) are a heterogeneous population within the TME and their prevalence significantly correlates with patient prognosis in a range of cancers. Macrophages display intrinsic radio-resistance and radiotherapy can influence TAM recruitment and phenotype. However, whether radiotherapy alone can effectively "reprogram" TAMs to display anti-tumor phenotypes appears conflicting. Here, we discuss the effect of radiation on macrophage recruitment and plasticity in cancer, while emphasizing the role of specific TME components which may compromise the tumor response to radiation and influence macrophage function. In particular, this review will focus on soluble factors (cytokines, chemokines and components of the complement system) as well as physical changes to the TME. Since the macrophage response has the potential to influence radiotherapy outcomes this population may represent a drug target for improving treatment. An enhanced understanding of components of the TME impacting radiation-induced TAM recruitment and function may help consider the scope for future therapeutic avenues to target this plastic and pervasive population.
Copyright © 2022 Beach, MacLean, Majorova, Arnold and Olcina.

Entities:  

Keywords:  complement system; extracellular matrix; hypoxia; macrophage polarization; macrophage recruitment; radiotherapy; tumor associated macrophages (TAM); tumor microenvironment

Year:  2022        PMID: 36249052      PMCID: PMC9559862          DOI: 10.3389/fonc.2022.1020606

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   5.738


  86 in total

1.  Intracellular Activation of Complement C3 Leads to PD-L1 Antibody Treatment Resistance by Modulating Tumor-Associated Macrophages.

Authors:  Haoran Zha; Xinxin Wang; Ying Zhu; Diangang Chen; Xiao Han; Fei Yang; Jianbao Gao; Chunyan Hu; Chi Shu; Yi Feng; Yulong Tan; Jinyu Zhang; Yongsheng Li; Yisong Y Wan; Bo Guo; Bo Zhu
Journal:  Cancer Immunol Res       Date:  2018-12-04       Impact factor: 11.151

2.  Complement-dependent modulation of antitumor immunity following radiation therapy.

Authors:  Michelle Elvington; Melissa Scheiber; Xiaofeng Yang; Katherine Lyons; Dustin Jacqmin; Casey Wadsworth; David Marshall; Kenneth Vanek; Stephen Tomlinson
Journal:  Cell Rep       Date:  2014-07-24       Impact factor: 9.423

3.  Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression.

Authors:  Yu Zhu; John M Herndon; Dorothy K Sojka; Ki-Wook Kim; Brett L Knolhoff; Chong Zuo; Darren R Cullinan; Jingqin Luo; Audrey R Bearden; Kory J Lavine; Wayne M Yokoyama; William G Hawkins; Ryan C Fields; Gwendalyn J Randolph; David G DeNardo
Journal:  Immunity       Date:  2017-08-15       Impact factor: 31.745

4.  Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice.

Authors:  Liufu Deng; Hua Liang; Byron Burnette; Michael Beckett; Thomas Darga; Ralph R Weichselbaum; Yang-Xin Fu
Journal:  J Clin Invest       Date:  2014-01-02       Impact factor: 14.808

5.  HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing.

Authors:  M Ivan; K Kondo; H Yang; W Kim; J Valiando; M Ohh; A Salic; J M Asara; W S Lane; W G Kaelin
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

6.  The cellular and molecular origin of tumor-associated macrophages.

Authors:  Ruth A Franklin; Will Liao; Abira Sarkar; Myoungjoo V Kim; Michael R Bivona; Kang Liu; Eric G Pamer; Ming O Li
Journal:  Science       Date:  2014-05-08       Impact factor: 47.728

7.  TGFβ Blockade Enhances Radiotherapy Abscopal Efficacy Effects in Combination with Anti-PD1 and Anti-CD137 Immunostimulatory Monoclonal Antibodies.

Authors:  María E Rodríguez-Ruiz; Inmaculada Rodríguez; Lina Mayorga; Tania Labiano; Benigno Barbes; Iñaki Etxeberria; Mariano Ponz-Sarvise; Arantza Azpilikueta; Elixabet Bolaños; Miguel F Sanmamed; Pedro Berraondo; Felipe A Calvo; Mary Helen Barcelos-Hoff; Jose L Perez-Gracia; Ignacio Melero
Journal:  Mol Cancer Ther       Date:  2019-01-25       Impact factor: 6.261

8.  Autocrine Complement Inhibits IL10-Dependent T-cell-Mediated Antitumor Immunity to Promote Tumor Progression.

Authors:  Yu Wang; Sheng-Nan Sun; Qing Liu; Yang-Yang Yu; Jian Guo; Kun Wang; Bao-Cai Xing; Qing-Feng Zheng; Michael J Campa; Edward F Patz; Shi-You Li; You-Wen He
Journal:  Cancer Discov       Date:  2016-06-13       Impact factor: 39.397

9.  Tissue-resident macrophages provide a pro-tumorigenic niche to early NSCLC cells.

Authors:  Erica Dalla; Andrew M Leader; Jessica LeBerichel; María Casanova-Acebes; Jovan Nikolic; Blanca M Morales; Markus Brown; Christie Chang; Leanna Troncoso; Steven T Chen; Ana Sastre-Perona; Matthew D Park; Alexandra Tabachnikova; Maxime Dhainaut; Pauline Hamon; Barbara Maier; Catherine M Sawai; Esperanza Agulló-Pascual; Markus Schober; Brian D Brown; Boris Reizis; Thomas Marron; Ephraim Kenigsberg; Christine Moussion; Philippe Benaroch; Julio A Aguirre-Ghiso; Miriam Merad
Journal:  Nature       Date:  2021-06-16       Impact factor: 69.504

10.  Macrophages are exploited from an innate wound healing response to facilitate cancer metastasis.

Authors:  Tamara Muliaditan; Jonathan Caron; Mary Okesola; James W Opzoomer; Paris Kosti; Mirella Georgouli; Peter Gordon; Sharanpreet Lall; Desislava M Kuzeva; Luisa Pedro; Jacqueline D Shields; Cheryl E Gillett; Sandra S Diebold; Victoria Sanz-Moreno; Tony Ng; Esther Hoste; James N Arnold
Journal:  Nat Commun       Date:  2018-07-27       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.